CL
FLGT icon

CIM LLC’s Fulgent Genetics FLGT Stock Holding History

CIM LLC’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,518
Closed -$325K – 152
2022
Q2 		$325K Sell
5,518
-32
-0.6% -$1.76K 0.07% 119
2022
Q1 		$319K Buy
5,550
+238
+4% +$15.7K 0.06% 118
2021
Q4 		$337K Buy
5,312
+522
+11% +$45.9K 0.06% 117
2021
Q3 		$370K Buy
4,790
+1,357
+40% +$123K 0.06% 118
2021
Q2 		$363K Buy
+3,433
New +$274K 0.06% 114

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CIM LLC's FLGT Position: Q3 2022 in Review

CIM LLC sold out of Fulgent Genetics (FLGT) in Q3 2022, closing a stake of 5,518 shares — an estimated $325K sold.

CIM LLC first reported a position in FLGT in Q2 2021 and held it in 5 quarters. The position peaked at $370K in Q3 2021. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

  • CIM LLC reported no remaining Fulgent Genetics position as of Q3 2022 after selling out during the quarter.
  • CIM LLC sold 5,518 Fulgent Genetics shares in Q3 2022, an estimated $325K.
  • CIM LLC first reported a position in Fulgent Genetics in Q2 2021 and held it in 5 quarters.
  • CIM LLC's Fulgent Genetics position peaked at $370K in Q3 2021.
  • 235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on CIM LLC's 13F filing for Q3 2022, filed 2 Nov 2022.